(Tromsø 02. June 2017) Børge Sørvoll, CFO of Biotec Pharmacon has today
purchased 5.738 shares in Biotec Pharmacon at NOK 6.03 per share. After this
transaction holds Sørvoll 17.428 shares and 82.500 options in Biotec Pharmacon
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no